Nicotinamide mononucleotide (NMN-C)

DIETARY_SUPPLEMENT2 trials

Sponsors

Seneque SA

Conditions

Healthy Volunteers

Unknown Phase

Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults

CompletedNCT04862338

Seneque SAHealthy Volunteers

Start: 2021-04-26End: 2022-04-04Updated: 2023-01-26

Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

CompletedNCT04910061

Seneque SAHealthy Volunteers

Start: 2021-08-05End: 2023-03-01Updated: 2023-03-30

Related Papers

A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults

Frontiers in Aging2022-05-0553 citations